famotidine has been researched along with Melanosis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Melanosis: Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, JAF | 1 |
| Lima, PB | 1 |
| Cassiano, DP | 1 |
| Espósito, ACC | 1 |
| Bagatin, E | 1 |
| Miot, LDB | 1 |
| Miot, HA | 1 |
1 trial available for famotidine and Melanosis
| Article | Year |
|---|---|
Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial.
Topics: Double-Blind Method; Famotidine; Humans; Ketotifen; Melanosis | 2022 |